Image credit: Wally Gobetz

National Cannabis Lobbying Falls, Again

The amount of money that cannabis-focused entities spent on cannabis lobbying at the federal level fell for the third quarter in a row, following an unprecedented rise in 2019.

Lobbying
New York

New York: Cannabis and the Cuomo Effect

While Cuomo’s scandals might have helped push legalization over the finish line in 2021, the latest fallout could cause delays in setting up the industry.

CBD

Cannabis and Clinical Trials: How the First Cannabis Extract Got FDA Approval

CSU Pueblo hosted a pharmacist at Greenwich Biosciences to talk about the company’s path with Epidiolex, a CBD-based medicine extracted from cannabis plants.